Department of Orthopaedics, Fourth Medical Center of PLA General Hospital, Beijing, China.
Department of Orthopaedics, The 943th Hospital of Joint Logistics Support force of PLA, Wu wei, China.
Orthop Surg. 2024 Jul;16(7):1648-1656. doi: 10.1111/os.14098. Epub 2024 May 22.
Percutaneous repair is an alternative to open surgical repair of the Achilles tendon with comparable, functional results and low re-rupture and infection rates; however, sural nerve injury is a known complication. The purpose of this study is to design a new surgical procedure, the minimally invasive peritendinous submembrane access technique (MIS-PSAT). It offers optimal results, with excellent functional outcomes, and with minimal soft tissue complications and sural nerve injury.
This retrospective study included 249 patients with acute closed Achilles tendon ruptures treated at our institution between 2009 and 2019. All patients underwent MIS-PSAT at our institution and were followed up for 8-48 months. Functional evaluation was based on the Achilles tendon total rupture score (ATRS) and the American Orthopedic Foot and Ankle Society Ankle-Hindfoot Scale (AOFAS-AHS), associated with local complications and isokinetic tests.
None of the patients had infection, necrosis, or sural nerve injury. Re-rupture occurred in two cases. The average times to return to work and sports was 10.4 and 31.6 weeks, respectively. The average ATRS and AOFAS-AHS scores were 90.2 and 95.7, respectively, with an excellent rate of 99.5%. Isokinetic tests showed that ankle function on the affected side was comparable with that on the healthy side (p > 0.05).
The MIS-PSAT for acute Achilles tendon rupture is easy to perform with few complications. Importantly, the surgical technique reduces the risk of sural nerve injuries. Patients have high postoperative satisfaction, low re-rupture rates, and muscle strength, and endurance can be restored to levels similar to those on the healthy side.
经皮修复是跟腱断裂的一种替代开放性手术修复方法,具有可比较的功能结果和较低的再断裂和感染率;然而,腓肠神经损伤是一种已知的并发症。本研究的目的是设计一种新的手术方法,即微创肌腱膜下膜内入路技术(MIS-PSAT)。它提供了最佳的结果,具有出色的功能结果,并且软组织并发症和腓肠神经损伤最小。
这是一项回顾性研究,纳入了 2009 年至 2019 年期间在我们机构接受治疗的 249 例急性闭合性跟腱断裂患者。所有患者均在我们机构接受了 MIS-PSAT 治疗,并随访 8-48 个月。功能评估基于跟腱总断裂评分(ATRS)和美国矫形足踝协会踝-后足评分(AOFAS-AHS),同时评估局部并发症和等速测试。
无感染、坏死或腓肠神经损伤病例。有两例再断裂。平均返回工作和运动的时间分别为 10.4 和 31.6 周。平均 ATRS 和 AOFAS-AHS 评分分别为 90.2 和 95.7,优良率为 99.5%。等速测试显示,患侧踝关节功能与健侧相似(p>0.05)。
MIS-PSAT 治疗急性跟腱断裂操作简单,并发症少。重要的是,该手术技术降低了腓肠神经损伤的风险。患者术后满意度高,再断裂率低,肌肉力量和耐力可恢复到与健侧相似的水平。